메뉴 건너뛰기




Volumn 5, Issue 1, 2015, Pages 33-42

New oral delivery system to improve absorption of berberine: Likely interaction of cationized chitosan with PG-P Pump

Author keywords

Berberine chloride; Bioavailability; Chitosan; N Acetylcysteine; Pg P; Tight junctions

Indexed keywords

ACETYLCYSTEINE; ANTILIPEMIC AGENT; BERBERINE; CHITIN; CHITOSAN; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR; MULTIDRUG RESISTANCE PROTEIN; PLACEBO; POLYSORBATE 80;

EID: 84922322638     PISSN: None     EISSN: 09754415     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (19)

References (42)
  • 3
    • 84890900990 scopus 로고    scopus 로고
    • Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells
    • Jan
    • Zhou Y, Cao S, Wang Y, Xu P, Yan J, Bin W, Qiu F, Kang N. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells. Fitoterapia. 2014 Jan: 92:230-7.
    • (2014) Fitoterapia , vol.92 , pp. 230-237
    • Zhou, Y.1    Cao, S.2    Wang, Y.3    Xu, P.4    Yan, J.5    Bin, W.6    Qiu, F.7    Kang, N.8
  • 4
    • 84866495078 scopus 로고    scopus 로고
    • Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment
    • Sep 22
    • Pisciotta L, Bellocchio A, Bertolini S. Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment. Lipids Health Dis. 2012 Sep 22;11:123.
    • (2012) Lipids Health Dis , vol.11 , pp. 123
    • Pisciotta, L.1    Bellocchio, A.2    Bertolini, S.3
  • 5
    • 71749102883 scopus 로고    scopus 로고
    • "Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor"
    • November
    • Wang, Yan-Xiang; Wang, Yu-Ping; Zhang, Hao; Kong, Wei-Jia; Li, Ying-Hong; Liu, Fei; Gao, Rong-Mei; Liu, Ting et al. (November 2009). "Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor". Bioorganic & Medicinal Chemistry Letters 19 (21): 6004-8.
    • (2009) Bioorganic & Medicinal Chemistry Letters , vol.19 , Issue.21 , pp. 6004-6008
    • Wang, Y.-X.1    Wang, Y.-P.2    Zhang, H.3    Kong, W.-J.4    Li, Y.-H.5    Liu, F.6    Gao, R.-M.7    Liu, T.8
  • 6
    • 47149089693 scopus 로고    scopus 로고
    • Combination of simvastatin with berberine improves the lipid-lowering efficacy
    • Aug
    • Kong WJ et al. Combination of simvastatin with berberine improves the lipid-lowering efficacy. Metabolism. 2008 Aug;57(8):1029-37
    • (2008) Metabolism , vol.57 , Issue.8 , pp. 1029-1037
    • Kong, W.J.1
  • 7
    • 84893982496 scopus 로고    scopus 로고
    • Nutraceutical approach to moderate cardiometabolic risk: Results of a randomized, double-blind and crossover study with, Armolipid Plus
    • Jan-Feb
    • Ruscica M et al. Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus. J Clin Lipidol. 2014 Jan-Feb;8(1):61-8
    • (2014) J Clin Lipidol , vol.8 , Issue.1 , pp. 61-68
    • Ruscica, M.1
  • 8
    • 84860585995 scopus 로고    scopus 로고
    • Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients
    • Dec
    • Marazzi G et al. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther. 2011 Dec;28(12):1105-13.
    • (2011) Adv Ther , vol.28 , Issue.12 , pp. 1105-1113
    • Marazzi, G.1
  • 9
    • 0035843962 scopus 로고    scopus 로고
    • Structural mechanism for statin inhibition of
    • May 11
    • Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science. 2001 May 11;292(5519):1160-4
    • (2001) HMG-CoA reductase. Science , vol.292 , Issue.5519 , pp. 1160-1164
    • Istvan, E.S.1    Deisenhofer, J.2
  • 10
    • 21244465525 scopus 로고    scopus 로고
    • Cholesterol and plant sterol absorption: Recent insights
    • Jul 4
    • Von Bergmann K, Sudhop T, Lütjohann D. Cholesterol and plant sterol absorption: recent insights. Am J Cardiol. 2005 Jul 4;96(1A):10D-14D.
    • (2005) Am J Cardiol , vol.96 , Issue.1 A , pp. 10D-14D
    • Von Bergmann, K.1    Sudhop, T.2    Lütjohann, D.3
  • 11
    • 78751647742 scopus 로고    scopus 로고
    • "Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats"
    • March
    • Wang Y, Campbell T, Perry B, Beaurepaire C, Qin L (March 2010). "Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats". Metabolism: Clinical and Experimental 60 (2): 298-305.
    • (2010) Metabolism: Clinical and Experimental , vol.60 , Issue.2 , pp. 298-305
    • Wang, Y.1    Campbell, T.2    Perry, B.3    Beaurepaire, C.4    Qin, L.5
  • 12
    • 70349157209 scopus 로고    scopus 로고
    • "Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high fat diet and streptozotocin"
    • August
    • Wang C, Li J, Lv X et al. (August 2009). "Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high fat diet and streptozotocin". European Journal of Pharmacology 620 (1-3): 131-7.
    • (2009) European Journal of Pharmacology , vol.620 , Issue.1-3 , pp. 131-137
    • Wang, C.1    Li, J.2    Lv, X.3
  • 13
    • 74049139484 scopus 로고    scopus 로고
    • "Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression"
    • September
    • Zhang H, Wei J, Xue R et al. (September 2009). "Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression". Metabolism: Clinical and Experimental 59 (2): 285-92.
    • (2009) Metabolism: Clinical and Experimental , vol.59 , Issue.2 , pp. 285-292
    • Zhang, H.1    Wei, J.2    Xue, R.3
  • 14
    • 47549100864 scopus 로고    scopus 로고
    • "Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine"
    • July
    • Zhang Y, Li X, Zou D et al. (July 2008). "Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine". The Journal of Clinical Endocrinology and Metabolism 93 (7): 2559-65.
    • (2008) The Journal of Clinical Endocrinology and Metabolism , vol.93 , Issue.7 , pp. 2559-2565
    • Zhang, Y.1    Li, X.2    Zou, D.3
  • 15
    • 84884547491 scopus 로고    scopus 로고
    • Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion
    • Oct
    • Pérez-Rubio KG et al. Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab Syndr Relat Disord. 2013 Oct;11(5):366-9.
    • (2013) Metab Syndr Relat Disord , vol.11 , Issue.5 , pp. 366-369
    • Pérez-Rubio, K.G.1
  • 16
    • 42949145899 scopus 로고    scopus 로고
    • "Efficacy of berberine in patients with type 2 diabetes mellitus"
    • May
    • Yin J, Xing H, Ye J (May 2008). "Efficacy of berberine in patients with type 2 diabetes mellitus". Metabolism: Clinical and Experimental 57 (5): 712-7.
    • (2008) Metabolism: Clinical and Experimental , vol.57 , Issue.5 , pp. 712-717
    • Yin, J.1    Xing, H.2    Ye, J.3
  • 17
    • 77955656527 scopus 로고    scopus 로고
    • "The anti-necrosis role of hypoxic preconditioning after acute anoxia is mediated by aldose reductase and sorbitol pathway in PC12 cells"
    • November
    • Wu LY, Ma ZM, Fan XL et al. (November 2009). "The anti-necrosis role of hypoxic preconditioning after acute anoxia is mediated by aldose reductase and sorbitol pathway in PC12 cells". Cell Stress & Chaperones 15 (4): 387-94.
    • (2009) Cell Stress & Chaperones , vol.15 , Issue.4 , pp. 387-394
    • Wu, L.Y.1    Ma, Z.M.2    Fan, X.L.3
  • 19
    • 57049090579 scopus 로고    scopus 로고
    • "Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression"
    • January
    • Kong WJ, Zhang H, Song DQ et al. (January 2009). "Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression". Metabolism 58 (1): 109-19.
    • (2009) Metabolism , vol.58 , Issue.1 , pp. 109-119
    • Kong, W.J.1    Zhang, H.2    Song, D.Q.3
  • 20
    • 82955235212 scopus 로고    scopus 로고
    • Berberine Inhibits Inflammatory Response and Ameliorates Insulin Resistance in Hepatocytes
    • December
    • Lou T et al. "Berberine Inhibits Inflammatory Response and Ameliorates Insulin Resistance in Hepatocytes." Inflammation. December 2011, Volume 34, Issue 6, pp 659-667
    • (2011) Inflammation , vol.34 , Issue.6 , pp. 659-667
    • Lou, T.1
  • 21
    • 74749103942 scopus 로고    scopus 로고
    • "Berberine Modulates Insulin Signaling Transduction in Insulin-resistant Cells"
    • December
    • Liu LZ, Cheung SC, Lan LL et al. (December 2009). "Berberine Modulates Insulin Signaling Transduction in Insulin-resistant Cells". Molecular and Cellular Endocrinology 317 (1-2): 148-53.
    • (2009) Molecular and Cellular Endocrinology , vol.317 , Issue.1-2 , pp. 148-153
    • Liu, L.Z.1    Cheung, S.C.2    Lan, L.L.3
  • 22
    • 59849110456 scopus 로고    scopus 로고
    • "Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 α expression and glucokinase activity"
    • October
    • Wang, ZQ; Lu; Leng; Fang; Chen; Wang; Dong; Yan (October 2008). "Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 α expression and glucokinase activity". World journal of gastroenterology 14 (39): 6004-11.
    • (2008) World journal of gastroenterology , vol.14 , Issue.39 , pp. 6004-6011
    • Wang, Z.Q.1    Lu2    Leng3    Fang4    Chen5    Wang6    Dong7    Yan8
  • 23
    • 77949336458 scopus 로고    scopus 로고
    • "Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics"
    • May
    • Gu Y, Zhang Y, Shi X et al. (May 2010). "Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics". Talanta 81 (3): 766-72.
    • (2010) Talanta , vol.81 , Issue.3 , pp. 766-772
    • Gu, Y.1    Zhang, Y.2    Shi, X.3
  • 24
    • 84935098094 scopus 로고    scopus 로고
    • Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: The roles of long chain fatty acids
    • Aug 20
    • Hafizi Abu Bakar M, Kian Kai C, Wan Hassan WN, Sarmidi MR, Yaakob H, Zaman Huri H. Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: the roles of long chain fatty acids. Diabetes Metab Res Rev. 2014 Aug 20. doi: 10.1002/dmrr.2601.
    • (2014) Diabetes Metab Res Rev
    • Hafizi Abu Bakar, M.1    Kian Kai, C.2    Wan Hassan, W.N.3    Sarmidi, M.R.4    Yaakob, H.5    Zaman Huri, H.6
  • 25
    • 85027931488 scopus 로고    scopus 로고
    • Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats
    • Jun
    • Chen W, et al. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech. 2011 Jun;12(2):705-11
    • (2011) AAPS PharmSciTech , vol.12 , Issue.2 , pp. 705-711
    • Chen, W.1
  • 27
    • 0036893418 scopus 로고    scopus 로고
    • P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers
    • Dec
    • Maeng HJ, Yoo HJ, Kim IW, Song IS, Chung SJ, Shim CK. P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers. J Pharm Sci. 2002 Dec;91(12):2614-21.
    • (2002) J Pharm Sci , vol.91 , Issue.12 , pp. 2614-2621
    • Maeng, H.J.1    Yoo, H.J.2    Kim, I.W.3    Song, I.S.4    Chung, S.J.5    Shim, C.K.6
  • 28
    • 0033980182 scopus 로고    scopus 로고
    • P-glycoprotein: A defense mechanism limiting oral bioavailability and CNS accumulation of drugs
    • Feb
    • Fromm MF. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int J Clin Pharmacol Ther. 2000 Feb;38(2):69-74.
    • (2000) Int J Clin Pharmacol Ther , vol.38 , Issue.2 , pp. 69-74
    • Fromm, M.F.1
  • 29
    • 0242552872 scopus 로고    scopus 로고
    • Importance of P-glycoprotein for drug disposition in humans
    • Nov
    • Fromm MF. Importance of P-glycoprotein for drug disposition in humans. Eur J Clin Invest. 2003 Nov;33 Suppl 2:6-9.
    • (2003) Eur J Clin Invest , vol.33 , pp. 6-9
    • Fromm, M.F.1
  • 30
  • 31
    • 84896985226 scopus 로고    scopus 로고
    • Trends in drug delivery through tissue barriers containing tight junctions
    • Apr 1
    • Tscheik C, Blasig IE, Winkler L. Trends in drug delivery through tissue barriers containing tight junctions. Tissue Barriers. 2013 Apr 1;1(2):e24565
    • (2013) Tissue Barriers , vol.1 , Issue.2
    • Tscheik, C.1    Blasig, I.E.2    Winkler, L.3
  • 33
    • 0035478758 scopus 로고    scopus 로고
    • Chitosan and its derivatives as intestinal absorption enhancers
    • Oct 1
    • Thanou M, Verhoef JC, Junginger HE. Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev. 2001 Oct 1;50 Suppl 1:S91-101.
    • (2001) Adv Drug Deliv Rev , vol.50 , pp. S91-S101
    • Thanou, M.1    Verhoef, J.C.2    Junginger, H.E.3
  • 34
    • 0035813752 scopus 로고    scopus 로고
    • Oral drug absorption enhancement by chitosan and its derivatives
    • Nov 5
    • Thanou M, Verhoef JC, Junginger HE. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev. 2001 Nov 5;52(2):117-26.
    • (2001) Adv Drug Deliv Rev , vol.52 , Issue.2 , pp. 117-126
    • Thanou, M.1    Verhoef, J.C.2    Junginger, H.E.3
  • 35
    • 43049096476 scopus 로고    scopus 로고
    • Chitosan-N-acetyl cysteine conjugates: In vitro evaluation of permeation enhancing and P-glycoprotein inhibiting properties
    • May
    • Schmitz T, Hombach J, Bernkop-Schnürch A. Chitosan-N-acetyl cysteine conjugates: in vitro evaluation of permeation enhancing and P-glycoprotein inhibiting properties. Drug Deliv. 2008 May;15(4):245-52.
    • (2008) Drug Deliv , vol.15 , Issue.4 , pp. 245-252
    • Schmitz, T.1    Hombach, J.2    Bernkop-Schnürch, A.3
  • 36
    • 33344454616 scopus 로고    scopus 로고
    • Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine
    • Mar 10
    • Werle M, Hoffer M. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release. 2006 Mar 10;111(1-2):41-6.
    • (2006) J Control Release , vol.111 , Issue.1-2 , pp. 41-46
    • Werle, M.1    Hoffer, M.2
  • 37
    • 63949085491 scopus 로고    scopus 로고
    • Trimethyl chitosan and its applications in drug delivery
    • May, Epub 2008 Dec 27
    • Mourya VK, Inamdar NN. Trimethyl chitosan and its applications in drug delivery. J Mater Sci Mater Med. 2009 May;20(5):1057-79. Epub 2008 Dec 27.
    • (2009) J Mater Sci Mater Med , vol.20 , Issue.5 , pp. 1057-1079
    • Mourya, V.K.1    Inamdar, N.N.2
  • 38
    • 3843146208 scopus 로고    scopus 로고
    • Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs
    • Sep
    • Van der Merwe SM, Verhoef JC, Verheijden JH, Kotzé AF, Junginger HE. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm. 2004 Sep;58(2):225-35.
    • (2004) Eur J Pharm Biopharm , vol.58 , Issue.2 , pp. 225-235
    • Van der Merwe, S.M.1    Verhoef, J.C.2    Verheijden, J.H.3    Kotzé, A.F.4    Junginger, H.E.5
  • 39
    • 0033007333 scopus 로고    scopus 로고
    • Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: In vitro evaluation in intestinal epithelial cells (Caco-2)
    • Feb
    • Kotzé AF et al. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2). J Pharm Sci. 1999 Feb;88(2):253-7.
    • (1999) J Pharm Sci , vol.88 , Issue.2 , pp. 253-257
    • Kotzé, A.F.1
  • 40
    • 28444456377 scopus 로고    scopus 로고
    • Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant
    • Jan
    • Takatsuka S, Kitazawa T, Morita T, Horikiri Y, Yoshino H. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant. Eur J Pharm Biopharm. 2006 Jan;62(1):52-8.
    • (2006) Eur J Pharm Biopharm , vol.62 , Issue.1 , pp. 52-58
    • Takatsuka, S.1    Kitazawa, T.2    Morita, T.3    Horikiri, Y.4    Yoshino, H.5
  • 41
    • 34248673162 scopus 로고    scopus 로고
    • Absorption enhancement of poorly absorbed hydrophilic compounds from various mucosal sites by combination of mucolytic agent and non-ionic surfactant
    • Jun 29
    • Takatsuka S, Morita T, Horikiri Y, Yamahara H, Saji H. Absorption enhancement of poorly absorbed hydrophilic compounds from various mucosal sites by combination of mucolytic agent and non-ionic surfactant. Int J Pharm. 2007 Jun 29;338(1-2):87-93.
    • (2007) Int J Pharm , vol.338 , Issue.1-2 , pp. 87-93
    • Takatsuka, S.1    Morita, T.2    Horikiri, Y.3    Yamahara, H.4    Saji, H.5
  • 42
    • 28744457833 scopus 로고    scopus 로고
    • Sublingual delivery of insulin: Effects of enhancers on the mucosal lipid fluidity and protein conformation, transport, and in vivo hypoglycemic activity
    • Dec
    • Cui CY et al. Sublingual delivery of insulin: effects of enhancers on the mucosal lipid fluidity and protein conformation, transport, and in vivo hypoglycemic activity. Biol Pharm Bull. 2005 Dec;28(12):2279-88.
    • (2005) Biol Pharm Bull , vol.28 , Issue.12 , pp. 2279-2288
    • Cui, C.Y.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.